Business Context and Reporting Period
This Form 8-K is a current report filed by MRI Interventions, Inc. (not Clearpoint Neuro, Inc.) on May 8, 2015. The report discloses a change in senior management effective May 8, 2015, immediately following the filing of the Company's Quarterly Report on Form 10-Q for the period ended March 31, 2015.
Key Financial Metrics
The filing text does not provide specific financial data such as revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and personnel changes.
Material Changes
- Executive Departure and Appointment: Harold A. Hurwitz succeeded David W. Carlson as Chief Financial Officer (CFO).
- Role Designation: Mr. Hurwitz also assumed the roles of designated principal financial officer and principal accounting officer for SEC reporting purposes.
- Timing: The transition occurred on May 8, 2015.
Management Commentary and Agreements
The principal terms of Mr. Hurwitz's employment were previously disclosed in a Form 8-K filed on March 17, 2015. The filing incorporates by reference several exhibits related to Mr. Hurwitz's appointment, including:
- Employment Offer Letter (Exhibit 10.1)
- Non-Competition Agreement (Exhibit 10.2)
- Non-Disclosure and Proprietary Rights Agreement (Exhibit 10.3)
- Form of Indemnification Agreement (Exhibit 10.4)
The filing does not contain forward-looking guidance, risk factors, or discussion of unusual items beyond the executive transition.
Investor Verification Checklist
- Verify the specific compensation terms and vesting schedules in the Employment Offer Letter filed as Exhibit 10.1 to the March 17, 2015 Form 8-K.
- Review the March 31, 2015 Form 10-Q to understand the financial context at the time of the CFO transition.
- Confirm the effective date of the departure of the former CFO, David W. Carlson.